# A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)

> **NCT01754818** · PHASE1 · COMPLETED · sponsor: **Stealth BioTherapeutics Inc.** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Bendavia 10mg
- **DRUG:** Bendavia 50mg
- **DRUG:** Bendavia 100mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01754818
- **Lead sponsor:** Stealth BioTherapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-01
- **Final completion:** 2013-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01754818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01754818, "A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01754818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*